Medical Marijuana, Inc. Appoints Blake N. Schroeder, Esq., As Vice President of Operations

MJNA Expands Executive Management Team, Adds Schroeder’s Experience With Rapid Business Growth and Streamlining Operations for Global Corporations

SAN DIEGO, March 29, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA) is proud to announce to shareholders and the public that the global industrial hemp investor and innovator has appointed Blake N. Schroeder, Esq., as Vice President of Operations at Medical Marijuana, Inc. Schroeder will also fill a dual role as Chief Executive Officer at Kannaway, LLC, an MJNA portfolio company.

A photo accompanying this announcement is available at

Schroeder brings extensive business experience in the nutrition industry ranging from legal and regulatory insight to overseeing all aspects of global sales, product development, marketing, distribution and operations. His legal and operations experience includes overseeing MonaVie’s legal status in Europe, Russia, Israel, Brazil, Mexico, Japan, Australia and New Zealand, then sales expansion into Europe, Russia, Israel and North America. Over a five year period, Schroeder grew European sales to $50 million. 

During his term at ForeverGreen, Schroeder was responsible for complete rebranding of the Company as well as expanding their largest market, Europe, with sales growth of 50% as President of the region.  Schroeder has operated businesses in countries around the globe, and extensively in North America, Europe and the Middle East.

“We are thrilled to make the announcement of Blake N. Schroeder, Esq., joining our executive leadership team,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Even in turbulent economic times, Blake has consistently proven his capability of increasing revenue and growing multi-national organizations. His background with multinational marketing companies in the health and nutrition field is an extremely valuable asset. We welcome him to the MJNA team.”

Schroeder states, “After a few visits with the executive management team at Medical Marijuana, Inc., I was crystal clear about the vision and passion behind the company, as well as the opportunity to lead in an emerging space. The choice to join the MJNA team was simple.” Schroeder continues, “My goal is to consistently deliver dramatic performance results, pioneer new business strategies and improve operations. Being a natural communicator has allowed me to implement strong training and leadership structure within companies to generate positive results. I’m looking forward to implementing these proven methods and expanding Medical Marijuana, Inc.’s brand presence worldwide.”

As part of the transition, former Kannaway CEO, Jeff Rogers, will assume the role of COO.  For more information on Medical Marijuana, Inc. and the portfolio company brands that it promotes, visit the Company website.

About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.

For more information, please visit the company's website at:

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photo is also available at Newscom,, and via AP PhotoExpress.

For further information, please contact:

Public Relations contact:
Andrew Hard
CMW Media
P. 888-829-0070

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA 

Toll Free: (877) 964.6463
Office/Direct: (858) 682-7500
Cell: (858) 682-7500